These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 5002903

  • 21. Investigation into the antibacterial activity in vitro of cement-antibiotic mixtures.
    Greco F, Rossi A, De Palma L, Spagnolo N.
    Ital J Orthop Traumatol; 1981 Apr; 7(1):103-13. PubMed ID: 6799427
    [Abstract] [Full Text] [Related]

  • 22. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
    Melby K, Midtvedt T, Dahl O.
    Chemotherapy; 1979 Apr; 25(5):286-95. PubMed ID: 113179
    [Abstract] [Full Text] [Related]

  • 23. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections.
    Daza R, Gutiérrez J, Piédrola G.
    Int J Antimicrob Agents; 2001 Sep; 18(3):211-5. PubMed ID: 11673032
    [Abstract] [Full Text] [Related]

  • 24. [Time factors in the bactericidal activity of gentamycin against E. coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas pyoceanea and Staphylococcus aureus].
    Helm E, Shah PM, Stille W.
    Med Welt; 1974 Apr 12; 25(15):644-8. PubMed ID: 4596609
    [No Abstract] [Full Text] [Related]

  • 25. Influence of various criteria for elimination of duplicates when calculating the prevalence and antibiotic susceptibility of microorganisms associated with urinary infections.
    Cebrián L, Rodríguez JC, Escribano I, Cascales E, López-Lozano JM, Royo G.
    Int J Antimicrob Agents; 2005 Feb 12; 25(2):173-6. PubMed ID: 15664489
    [Abstract] [Full Text] [Related]

  • 26. Comparative in vitro antibacterial activities of cefetamet (Ro 15-8074/005), a new oral cephalosporin, and eight other oral antimicrobials.
    Rozgonyi F, Papp-Falusi E, Varga J, Rozgonyi-Szitha K.
    J Chemother; 1989 Jul 12; 1(4 Suppl):119-22. PubMed ID: 16312332
    [No Abstract] [Full Text] [Related]

  • 27. [Drug sensitivity of bacteria isolated from clinical samples (author's transl)].
    Sawatari K, Mochida C, Iori F, Hayashi A, Nasu M.
    Jpn J Antibiot; 1980 Jan 12; 33(1):87-96. PubMed ID: 6990050
    [No Abstract] [Full Text] [Related]

  • 28. [Problems in the determination of susceptibility of bacteria using the agar diffusion test. Correlation statistics and construction of a decisive procedure].
    Kaufmann H, Neussel H, Linzenmeier G.
    Arzneimittelforschung; 1973 Jun 12; 23(6):743-6. PubMed ID: 4199199
    [No Abstract] [Full Text] [Related]

  • 29. Totally synthetic medium for susceptibility testing.
    Lawrence RM, Hoeprich PD.
    Antimicrob Agents Chemother; 1978 Mar 12; 13(3):394-8. PubMed ID: 122521
    [Abstract] [Full Text] [Related]

  • 30. Extended-spectrum β-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system.
    Espinar MJ, Rocha R, Ribeiro M, Gonçalves Rodrigues A, Pina-Vaz C.
    J Med Microbiol; 2011 Jun 12; 60(Pt 6):756-760. PubMed ID: 21330411
    [Abstract] [Full Text] [Related]

  • 31. A regional survey of the resistance to beta-lactam antibiotics in clinical isolates of (facultative) aerobic micro-organisms.
    Stobberingh EE, Philips JM, Houben AW, van Boven CP.
    Drugs; 1988 Jun 12; 35 Suppl 2():41-4. PubMed ID: 3135169
    [Abstract] [Full Text] [Related]

  • 32. Searching for a potential antibacterial lead structure against bacterial biofilms among new naphthoquinone compounds.
    Moreira CS, Silva AC, Novais JS, Sá Figueiredo AM, Ferreira VF, da Rocha DR, Castro HC.
    J Appl Microbiol; 2017 Mar 12; 122(3):651-662. PubMed ID: 27930849
    [Abstract] [Full Text] [Related]

  • 33. Agar shake tube technique for simultaneous determination of aerobic and anaerobic susceptibility to antibiotics.
    Evans JB, Harrell LJ.
    Antimicrob Agents Chemother; 1977 Oct 12; 12(4):534-6. PubMed ID: 335961
    [Abstract] [Full Text] [Related]

  • 34. The effect of fungal metabolites and of coriander seeds on the growth of pathogenic bacteria.
    Dwivedi R.
    Ann Inst Pasteur (Paris); 1972 Aug 12; 123(2):311-4. PubMed ID: 4632293
    [No Abstract] [Full Text] [Related]

  • 35. [Resistance determination against pyridine-3-carbonic acid hydroxymethylamide (nikoform, bilamide)].
    Patsch R, Höhne C.
    Z Allg Mikrobiol; 1970 Aug 12; 10(6):397-403. PubMed ID: 4249608
    [No Abstract] [Full Text] [Related]

  • 36. In vitro susceptibilities of canine urinary bacteria to selected antimicrobial agents.
    Rohrich PJ, Ling GV, Ruby AL, Jang SS, Johnson DL.
    J Am Vet Med Assoc; 1983 Oct 15; 183(8):863-7. PubMed ID: 6415021
    [Abstract] [Full Text] [Related]

  • 37. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Tan TY, Ng SY, Teo L, Koh Y, Teok CH.
    J Clin Pathol; 2008 May 15; 61(5):642-4. PubMed ID: 18057079
    [Abstract] [Full Text] [Related]

  • 38. Waste water bacterial isolates resistant to heavy metals and antibiotics.
    Filali BK, Taoufik J, Zeroual Y, Dzairi FZ, Talbi M, Blaghen M.
    Curr Microbiol; 2000 Sep 15; 41(3):151-6. PubMed ID: 10915198
    [Abstract] [Full Text] [Related]

  • 39. Laboratory evaluation of amoxycillin, a new semi-synthetic pencillin.
    Shimizu T.
    Jpn J Antibiot; 1974 Aug 15; 27(4):526-31. PubMed ID: 4612194
    [No Abstract] [Full Text] [Related]

  • 40. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H.
    Jpn J Antibiot; 1995 Sep 15; 48(9):1131-60. PubMed ID: 7474333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.